Omicron variant uncertainty should put investors off amateur virology

Here are just some of the things we do not know about the Omicron variant of Covid-19: the severity and transmissibility of infections, the efficacy of the current crop of vaccines against the new strain and the degree to which Omicron has spread around the world.In short, there is much we do not know about the variant, certainly not enough to gauge its impact on the global economy and financial markets. Yet, this has not stopped investors from reprising their roles as amateur virologists.Ever…

Read the original article at South China Morning Post